About: CHEMOPREVENTION OF PROSTATE CARCINOMA     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
  • www.urol.cz
Description
  • Chemoprevence karcinomu prostaty (cs)
  • Introduction: Prostate cancer is the most common tumor in the male population in Western Europe and USA. In the Czech Republic incidence is 96.87/100 000 inhabitants (NOR 2005). Prostate cancer is third most frequent causation of death for malignant tumor (28.52/1000 inhabitants). Prostate cancer chemoprevention can be described as the administration of natural products and pharmaceutical agents that inhibit one or more steps in the natural history of prostatic carcinogenesis. In recent, prostate carcinoma is the most common cancer in European and American men. Prostate cancer is an excellent target for chemoprevention strategies; given its late age of onset, any delay in carcinogenesis would lead to a reduction in its incidence. In 2003, the Prostate Cancer Prevention Trial (PCPT) became the first phase III clinical trial of prostate cancer prevention. This landmark study was terminated early due to the 24.8% reduction of prostate cancer prevalence over a 7-year period in those men t
  • Introduction: Prostate cancer is the most common tumor in the male population in Western Europe and USA. In the Czech Republic incidence is 96.87/100 000 inhabitants (NOR 2005). Prostate cancer is third most frequent causation of death for malignant tumor (28.52/1000 inhabitants). Prostate cancer chemoprevention can be described as the administration of natural products and pharmaceutical agents that inhibit one or more steps in the natural history of prostatic carcinogenesis. In recent, prostate carcinoma is the most common cancer in European and American men. Prostate cancer is an excellent target for chemoprevention strategies; given its late age of onset, any delay in carcinogenesis would lead to a reduction in its incidence. In 2003, the Prostate Cancer Prevention Trial (PCPT) became the first phase III clinical trial of prostate cancer prevention. This landmark study was terminated early due to the 24.8% reduction of prostate cancer prevalence over a 7-year period in those men t (en)
Title
  • CHEMOPREVENTION OF PROSTATE CARCINOMA
  • CHEMOPREVENTION OF PROSTATE CARCINOMA (en)
  • Chemoprevence karcinomu prostaty (cs)
skos:prefLabel
  • CHEMOPREVENTION OF PROSTATE CARCINOMA
  • CHEMOPREVENTION OF PROSTATE CARCINOMA (en)
  • Chemoprevence karcinomu prostaty (cs)
skos:notation
  • RIV/61989592:15110/08:00007485!RIV09-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 359746
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/08:00007485
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • prostate carcinoma; chemoprevention (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...i/riv/kodPristupu
http://linked.open...ontrolniKodProRIV
  • [61CBCF4B5019]
http://linked.open...telVyzkumneZpravy
  • Urologická klinika Olomouc
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...iv/tvurceVysledku
  • Vidlář, Aleš
  • Študent, Vladimír
  • Hrabec, Martin
  • Vrtal, Radovan
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 78 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software